Tranexamic Acid and Tourniquet: Which Combination Reduces Blood Loss Most Effectively?

IF 0.7 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Nigerian Journal of Clinical Practice Pub Date : 2024-04-01 Epub Date: 2024-04-29 DOI:10.4103/njcp.njcp_3_24
H C Bayrak, I F Adiguzel, M Demir, A O Tarlacık
{"title":"Tranexamic Acid and Tourniquet: Which Combination Reduces Blood Loss Most Effectively?","authors":"H C Bayrak, I F Adiguzel, M Demir, A O Tarlacık","doi":"10.4103/njcp.njcp_3_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Blood loss during and after total knee arthroplasty (TKA) can lead to substantial morbidity and the need for blood transfusions. There are several methods to minimize blood loss and decrease transfusion rates in patients undergoing TKA. Tranexamic acid, an antifibrinolytic agent with known efficacy for achieving these goals, is combined with tourniquets to reduce bleeding in arthroplasty surgeries. Our study investigated the effects of various combinations of tranexamic acid and tourniquet use on bleeding in knee arthroplasty in 558 patients.</p><p><strong>Aim: </strong>We aimed to determine the method that would provide the least blood loss and transfusion need in knee arthroplasty surgery.</p><p><strong>Methods: </strong>Between January 2018 and December 2022, 558 patients aged between 55 and 85 years underwent TKA surgery for grade 4 gonarthrosis in our clinic, and their decrease in hemoglobin value and whether they were transfused or not were analyzed. The patients were divided into four groups based on use of tranexamic acid and tourniquet. Demographic variables and patient data (body mass index, INR values, and preoperative hemoglobin values) were recorded.</p><p><strong>Results: </strong>There were 558 patients with a mean age of 68.19 (67 ± 6.949) years. In group 1, tranexamic acid was not used in 128 patients and tourniquet was used only during cementation; in group 2, in 132 patients, tranexamic acid was not used and tourniquet was used throughout the surgery; in group 3, in 158 patients, tranexamic acid was used and tourniquet was used throughout the surgery; in group 4, in 140 patients, tranexamic acid was used and tourniquet was used only during cementation. The decrease in hemoglobin value and transfusion rate was lowest in group 3 and highest in group 1. Besides, there was a greater decrease in hemoglobin value in group 2 than in group 4 and the transfusion rate was similar.</p><p><strong>Conclusions: </strong>This clinical study showed that using tranexamic acid and a tourniquet throughout surgery significantly reduced the decrease in hemoglobin value and the need for transfusion.</p>","PeriodicalId":19431,"journal":{"name":"Nigerian Journal of Clinical Practice","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nigerian Journal of Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/njcp.njcp_3_24","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Blood loss during and after total knee arthroplasty (TKA) can lead to substantial morbidity and the need for blood transfusions. There are several methods to minimize blood loss and decrease transfusion rates in patients undergoing TKA. Tranexamic acid, an antifibrinolytic agent with known efficacy for achieving these goals, is combined with tourniquets to reduce bleeding in arthroplasty surgeries. Our study investigated the effects of various combinations of tranexamic acid and tourniquet use on bleeding in knee arthroplasty in 558 patients.

Aim: We aimed to determine the method that would provide the least blood loss and transfusion need in knee arthroplasty surgery.

Methods: Between January 2018 and December 2022, 558 patients aged between 55 and 85 years underwent TKA surgery for grade 4 gonarthrosis in our clinic, and their decrease in hemoglobin value and whether they were transfused or not were analyzed. The patients were divided into four groups based on use of tranexamic acid and tourniquet. Demographic variables and patient data (body mass index, INR values, and preoperative hemoglobin values) were recorded.

Results: There were 558 patients with a mean age of 68.19 (67 ± 6.949) years. In group 1, tranexamic acid was not used in 128 patients and tourniquet was used only during cementation; in group 2, in 132 patients, tranexamic acid was not used and tourniquet was used throughout the surgery; in group 3, in 158 patients, tranexamic acid was used and tourniquet was used throughout the surgery; in group 4, in 140 patients, tranexamic acid was used and tourniquet was used only during cementation. The decrease in hemoglobin value and transfusion rate was lowest in group 3 and highest in group 1. Besides, there was a greater decrease in hemoglobin value in group 2 than in group 4 and the transfusion rate was similar.

Conclusions: This clinical study showed that using tranexamic acid and a tourniquet throughout surgery significantly reduced the decrease in hemoglobin value and the need for transfusion.

氨甲环酸和止血带:哪种组合能最有效地减少失血?
背景:全膝关节置换术(TKA)期间和术后失血会导致严重的发病率和输血需求。有几种方法可以最大限度地减少失血,降低接受全膝关节置换术患者的输血率。氨甲环酸是一种抗纤维蛋白溶解剂,具有实现上述目标的已知疗效,它与止血带结合使用可减少关节置换手术中的出血。我们的研究调查了氨甲环酸和止血带的不同组合对558例膝关节置换术患者出血的影响。目的:我们旨在确定膝关节置换术手术中失血量和输血需求最少的方法:2018年1月至2022年12月期间,558名年龄在55岁至85岁之间的患者在我院接受了4级冈关节病的TKA手术,分析了他们的血红蛋白值下降情况以及是否输血。根据氨甲环酸和止血带的使用情况将患者分为四组。记录了人口统计学变量和患者数据(体重指数、INR 值和术前血红蛋白值):结果:558 名患者的平均年龄为 68.19(67 ± 6.949)岁。在第 1 组中,128 名患者未使用氨甲环酸,仅在骨水泥固定过程中使用止血带;在第 2 组中,132 名患者未使用氨甲环酸,在整个手术过程中使用止血带;在第 3 组中,158 名患者使用氨甲环酸,在整个手术过程中使用止血带;在第 4 组中,140 名患者使用氨甲环酸,仅在骨水泥固定过程中使用止血带。第 3 组的血红蛋白值和输血率下降幅度最小,第 1 组最高;此外,第 2 组的血红蛋白值下降幅度大于第 4 组,输血率相近:这项临床研究表明,在整个手术过程中使用氨甲环酸和止血带可显著减少血红蛋白值的下降和输血需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nigerian Journal of Clinical Practice
Nigerian Journal of Clinical Practice MEDICINE, GENERAL & INTERNAL-
CiteScore
1.40
自引率
0.00%
发文量
275
审稿时长
4-8 weeks
期刊介绍: The Nigerian Journal of Clinical Practice is a Monthly peer-reviewed international journal published by the Medical and Dental Consultants’ Association of Nigeria. The journal’s full text is available online at www.njcponline.com. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal makes a token charge for submission, processing and publication of manuscripts including color reproduction of photographs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信